Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07242391 · ClinicalTrials.gov registry record
Menopausal Hormone Therapy And Left Ventricular Function
A clinical trial, sponsored by Mayo Clinic.
- Not yet
- Registry status
- 50
- Enrollment target
NCT07242391: Clinical Trial study, sponsored by Mayo Clinic.
NCT07242391 is a clinical trial that has not yet begun recruiting, run by Mayo Clinic. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07242391 has not yet begun recruiting, sponsored by Mayo Clinic.
- NOT YET RECRUITING
- Registry status
- 50 participants
- Enrollment target
Study Summary
The purpose of this study is to compare left ventricular stroke volume and heart rate responses to bursts of SNA between PMF using, and not using, MHT.
Primary Outcome
Left ventricular stroke volume is the amount of blood pumped from the left ventricle per heartbeat (mL)
Interventions
- DRUG Menopausal Hormone Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2026-07 |
| Est. Completion | 2027-12 |
What is known before NCT07242391 opens enrollment
NCT07242391 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Menopausal Hormone Therapy is the first listed.
NCT07242391 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07242391 about?
NCT07242391 is a clinical study titled "Menopausal Hormone Therapy And Left Ventricular Function". The purpose of this study is to compare left ventricular stroke volume and heart rate responses to bursts of SNA between PMF using, and not using, MHT.
What is the current status of trial NCT07242391?
This trial is currently not yet recruiting. The enrollment target is 50 participants. The study started on 2026-07. Estimated completion is 2027-12.
What interventions are being tested in trial NCT07242391?
The interventions under investigation include: Menopausal Hormone Therapy (DRUG).
Who is sponsoring clinical trial NCT07242391?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia